glp-1 drugs companies Market Overview: Agonists and the Obesity Market | Blog Market Overview: GLP-1 Agonists and
Description
AstraZeneca, Novo Nordisk A/S, Eli Lilly and Company, Sanofi and Hypera S.A
No injections needed just a daily tablet
Compare top GLP-1 agonists for weight lossSemaglutide vs
Glucagon-like peptide-1 (GLP-1) receptor agonists are a newer class of diabetes drugs that have the potential to double as weight loss drugs, widening their lucrative market potentials
